Cargando…
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease
Airway inflammation is a major contributing factor in both asthma and chronic obstructive pulmonary disease (COPD) and represents an important target for treatment. Inhaled corticosteroids (ICS) as monotherapy or in combination therapy with long-acting β(2)-agonists or long-acting muscarinic antagon...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825643/ https://www.ncbi.nlm.nih.gov/pubmed/31549299 http://dx.doi.org/10.1007/s40265-019-01198-7 |